key: cord-0901549-dsw28esb
authors: Inoue, Kosuke; Beekley, James; Goto, Atsushi; Jeon, Christie Y.; Ritz, Beate R.
title: Depression and Cardiovascular Disease Events among Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis with Bias Analysis
date: 2020-09-02
journal: J Diabetes Complications
DOI: 10.1016/j.jdiacomp.2020.107710
sha: e0a86db587c315c6472a95fe3d629471bebddf53
doc_id: 901549
cord_uid: dsw28esb

Aims To provide updated systematic and quantitative summary of the association between depression and the risk of CVD events among individuals with type 2 diabetes. We also aimed to examine the sensitivity of the association to uncontrolled confounding. Methods Data sources included Medline, Embase, and PsycInfo through September 2019. Two independent reviewers selected cohort studies that evaluated the association between depression and fatal or non-fatal CVD events among individuals with type 2 diabetes. Bias analysis was performed using the bias formula approach. Results Of 2,527 citations screened, 17 eligible studies with a total of 1,033,131 participants were identified. Based on random-effects meta-analysis, depression was associated with higher risks of non-fatal CVD events (relative risk 1.35, 95% confidence interval [CI] 1.20 to 1.53) and fatal CVD event (relative risk 1.47, 95% CI 1.21 to 1.77). Bias analysis indicated that unmeasured confounders alone may not explain the observed association between depression and CVD events among individuals with type 2 diabetes. Conclusions Depression was associated with a higher risk of non-fatal and fatal CVD events among individuals with type 2 diabetes. Our findings provide updated and robust evidence about the association between depression and CVD events among individuals with type 2 diabetes.

Cardiovascular disease (CVD) killed 17.9 million people globally in 2016, making it the most common cause of death (31%) among all causes (1). Diabetes, one of the main risk factors for CVD, affects approximately 425 million adults and imposes substantial health and economic burden on the global population, resulting in 4 million deaths and $727 billion in health expenditure worldwide in 2017 (2) . In response to these public health crises, as an essential part of the Sustainable Development Goals (SDGs), the United Nations has proposed to reduce morbidity and mortality for non-communicable diseases including CVD and diabetes, by onethird, by 2030 (3) . Therefore, understanding the major risk factors for CVD among patients with diabetes and mitigating the risks of CVD events is imperative to achieving this challenging goal.

Depression is closely interrelated with CVD and diabetes (4) (5) (6) . According to the INTERHEART study, psychosocial stress accounts for approximately 30% of the attributable risk of acute myocardial infarction, ranking it third after lipids and smoking (7) . In addition, the prevalence of depression in patients with type 2 diabetes is approximately twice as high as for those without diabetes (8) . It is also known that diabetic patients suffer from distress related to chronic disease management, necessary lifestyle changes, and other long-term adverse health outcomes related to diabetes (9) . While a previous meta-analysis more than 7 years ago showed that depression increases the risk of cardiovascular mortality among patients with type 2 diabetes (10), a comprehensive review that details the association between depression and incident nonfatal CVD events among diabetic patients is lacking. Given the large lifestyle and economic impacts of CVD events even without causing death (1,11), clarifying the impact of depression on non-fatal CVD events with the most recent data is important.

Depression and CVD share many risk factors, including socioeconomic status or its components income, educational attainment, and occupational status (4, 12) . While data for income and/or educational levels are often available to control for socioeconomic status in observational studies related to diabetes, mental health, and CVD, employment status has not been included in most of the previous studies. Recent studies have shown that unemployment is a risk factor of depression (13) and CVD events (14, 15) independently of other socioeconomic factors (e.g., income, education, and marital status) indicating the importance of additionally controlling for employment status (prior to the onset of depression). Bias analysis for uncontrolled confounding is a standard strategy to mitigate and assess the magnitude of this limitation in studies with unmeasured confounding. While this approach allows to more validly estimate the risk of CVD among diabetic patients with depression compared to those without depression, few metaanalyses of observational studies have employed this method thus far (16, 17) .

In the present systematic review and meta-analysis, we thus aimed to investigate the association between depression and the risk of CVD events among patients with type 2 diabetes. Given the potential for confounding bias due to unmeasured confounders such as employment status in observational studies, we also performed a bias analysis to evaluate the robustness of our findings to this common bias.

J o u r n a l P r e -p r o o f Table 1 ).

The present study followed the recommendations of the Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group (18) .

Two investigators (the first and second authors) independently evaluated the articles for eligibility. The inclusion criteria were: 1) a cohort study of people diagnosed with diabetes (defined clinically or by self-report) either as total sample or subgroup, 2) CVD events (see Table 1 for details in the assessment of CVD in each study) reported as the study outcome, and 3) the association between depression and CVD events during follow up was estimated in those with diabetes. Cohort studies were defined as those that prospectively identified a group of people, assessed exposures of interest, and followed them for the incidence of outcome events or those that used existing data records to retrospectively identify a group of people in whom exposure (i.e. depression) was assessed prior to the occurrence of outcome (i.e. CVD) events J o u r n a l P r e -p r o o f Journal Pre-proof (17) . We restricted our analyses to cohort studies to assure the timing for the onset such that CVD events did not affect depression rather than the other way around among those with type 2 diabetes. We included studies that identified depression by applying standardized screening tools or clinical criteria or identified in medical records. We determined the eligibility of the candidate studies by retrieving and screening the full text. All discrepancies were resolved by consensus after discussion that also included co-authors.

We extracted the following information; study characteristics (first author name, publication year, country of study, length of follow-up, study design and sample size), participant characteristics (age, sex, diabetes assessment, CVD history), exposure assessment, outcome assessment, adjustment factors, analysis strategy, and multivariable-adjusted relative risks and variance. If the appropriate information was missing, we requested this from the investigators. Two investigators (the first and second authors) independently extracted data and all discrepancies were resolved by discussion with co-authors.

To assess study quality, we evaluated sources of participants, comparability between respondents and non-respondents, exposure assessment, outcome assessment, and statistical quality (17) . As the scoring itself submerges detail information of each study, we chose not to employ a scoring system to formally rate study quality (19) .

Relative Risks (RRs) were estimated based on hazard ratios (HRs) reported in studies for CVD events among depressed and non-depressed study populations with diabetes since all cohort studies used Cox proportional hazard models. For studies that quantified HRs of CVD events using participants without diabetes and depression as a reference group, we calculated the HRs of CVD events for diabetic patients with depression relative to diabetic patients without depression using the method proposed by Altman and Bland (20) . For studies that reported multiple estimates, we selected the estimate which most closely adjusted for age, sex, race, socioeconomic status, and comorbidities. If studies presented the HRs according to the severity of depression, we used the estimates of the most severe depression group (21) .

The potential for publication bias was assessed using funnel plots, Begg's test (22) , and Egger's test (23) . We summarized the effect estimates using a random effects model (24) . The statistical heterogeneity of relative risks across studies was assessed using Cochrane's Q test and I 2 statistics (25, 26) . Low, moderate, and high degree of heterogeneity was defined as I 2 ≤25%, 25-75%, and >75%, respectively. We additionally performed stratified analyses by study location (US (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) or Non-US (38-43)), length of follow-up (>6 years (27, 28, 33, 35, (37) (38) (39) (40) 43) vs. ≤6 years (29) (30) (31) (32) 34, 36, 41, 42) ), inclusion criteria (including previous CVD (28) (29) (30) (31) (32) (34) (35) (36) (37) (38) (39) 41) vs not (27, 33, 40, 42, 43) ), diabetes assessment (type 2 (27, (30) (31) (32) (33) (34) (35) 38, (40) (41) (42) vs. type unclear (28, 29, 36, 37, 39, 43) ) and non-fatal CVD outcomes (including stroke (27, 31, 36, 40) vs. not (28) (29) (30) (32) (33) (34) (35) (36) (37) (38) (39) (41) (42) (43) ). P values for comparisons between subgroups were computed using the method proposed by Altman and Bland (20) . An additional sensitivity analysis removing each study one at the time was also conducted to examine the magnitude of influence of each study on pooled estimates.

We performed a bias analysis to investigate the potential impact of uncontrolled confounding by an unmeasured confounder. Because none of the studies included in this meta-analysis controlled for employment status as an important confounders between depression and CVD events (Supplementary Figure 1) , we used employment status for assessing the potential influence due to unmeasured confounders on our results in this bias analysis. We assigned plausible prevalence estimates for the unmeasured unemployment among diabetic patients without depression (10%), and among diabetic patients with depression (10%, 15%, 20%, or 25%), and the relative risks relating the unmeasured employment status and cardiovascular disease (a wide range of relative risks from 1.0 to 5.0), based on prior studies (14, 15, 44, 45) . Using these assigned values, we computed the adjusted relative risks, and 95% confidence intervals (CI), externally adjusted for the unmeasured employment status. In our bias analysis, we divided the observed relative risk of each study by a bias factor, which is the degree of bias due to failure to adjust for employment status. We assigned the same bias factor to all studies (except Hamieh et al (43) . because this study restricted participants to employees) and pooled the bias-adjusted relative risks using a random effects model. More details about the bias analysis methods are described in Supplementary Table 2 and elsewhere (16, 17) . All statistical analysis was performed using STATA version 15.

After applying our inclusion and exclusion criteria, we identified 17 studies (1,033,131 participants) that met the inclusion criteria for our meta-analysis (Figure 1 ) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) . The number J o u r n a l P r e -p r o o f Journal Pre-proof of participants in each study ranged from 133 to 933,211, with a mean age range of 47.8-75.6 years ( Table 1) . The follow-up period ranged from 1.5 to 20 years. All studies included in the meta-analysis adjusted for age and sex, while other factors such as socioeconomic status and comorbidities were less consistently included in fully adjusted models. Further detail with a quality assessment of each study is shown in Supplementary Table 3 .

The random effects meta-analysis indicated that depression was associated with higher risk of non-fatal CVD event (relative risk = 1.35, 95% CI = 1.20 to 1.53) and fatal CVD event (relative risk = 1.47, 95% CI = 1.21 to 1.77) ( For non-fatal CVD events, we found evidence of heterogeneity in the results according to inclusion criteria (including previous CVD or not) ( Table 2) . On the other hand, stratifying by the length of follow-up (>6 years vs ≤6 years), diabetes assessment (type 2 vs type unclear), or CVD outcome definition (including stroke or not) did not result in more than minimal heterogeneity. For fatal CVD events, we did not find evidence of heterogeneity in the stratified analysis (i.e. study location, and length of follow-up) or the overall result. No particular study was identified as influential in leave-one-out sensitivity analysis (Supplementary Figure 3) .

The bias analysis indicated that unmeasured unemployment alone is unlikely to explain the observed association between depression and CVD events among individuals with type 2 diabetes (Figure 3, Supplementary Table 4) . To explain the association between depression and non-fatal CVD events, unemployment (assuming a basic prevalence of unemployment among diabetic patients -without depression -of 10%) would have had to be much more prevalent in diabetic patients with depression (>25%) and also have a very strong association with non-fatal CVD events (RR >5.0) among individuals with type 2 diabetes. Similarly, to account for the association between depression and fatal CVD events, unemployment status would have needed to be much more highly prevalent in diabetic patients with depression (>25%) and have a strong association with fatal CVD events (RR >5.0) among individuals with type 2 diabetes.

In this meta-analysis of 1,033,131 patients with type 2 diabetes from 17 studies, we observed a higher risk of both non-fatal and fatal CVD events among those with depression compared with those without depression. Bias analysis indicated that the observed association between depression and CVD events among patients with type 2 diabetes is unlikely to be entirely due to confounding by an unmeasured (uncontrolled) co-factor such as unemployment. Given the high prevalence of depression in patients with type 2 diabetes, our findings highlight that mental health management for diabetic patients may reduce their risk of CVD events.

Our findings advance our current state of knowledge about the link between depression and CVD among patients with diabetes. A prior meta-analysis showed that depression was associated with fatal CVD events among patients with type 2 diabetes (HR 1.39, 95% CI = 1.11 to 1.73) (10).

We have updated the results including 3 additional large cohort studies on this topic published between 2013 and 2019 (35, 36, 41) . In addition, the risk of non-fatal CVD events due to depression in diabetic patients has not been adequately established. Although recent metaanalyses reported the association between depression and subsequent CVD events (46, 47) , these studies have limited information involving 9-11 studies, requiring a more comprehensive systematic review and a meta-analysis on this topic. Furthermore, given that depression and CVD share many common causes (4, 12) , it is critically important to assess the robustness of the summary estimates to uncontrolled confounding as this is one of the common and important potential biases in observational studies (16) . In this context, our meta-analytic findings are based on the most updated information through 2019 , and along with our bias analysis, highlight that depression in patients with type 2 diabetes may need to be seriously considered as J o u r n a l P r e -p r o o f depression may increase the risks of not only mortality but also non-fatal CVD events which are a strong predictor of health-related quality of life and economic burden (1,11).

There are several mechanisms that could explain why depression increases the risk of CVD events in patients with type 2 diabetes. Depression induces the following biological responses which are well-known risk factors of CVD events; including alterations of autonomic nervous system activity, decrease of heart-rate variability, the elevation of heart rate, catecholamine levels, and inflammatory activity, and the induction of endothelial and platelet dysfunction (48) (49) (50) (51) (52) (53) . In addition, the hypothalamic-pituitary-adrenal axis, which is essential for regulating glucocorticoid production by the adrenal glands, is prone to dysregulation with low socioeconomic status and poor health behaviors in those with a genetic predisposition (4). Such dysfunction may exacerbate the development of diabetes, metabolic syndrome, and insulin resistance, and increase the risk of having CVD events (54) . Depressive symptoms are also linked to behaviors such as failure to stop smoking, sedentariness (55), low physical activities (56) , poor adherence to medication (57) , poor diets, self-neglect, and decreased self-esteem (4), and all of these may also contribute to the incidence of CVD events.

We found between-study heterogeneity for non-fatal CVD events risk with depression by study location (US or Non-US). Given the variability of clinical guidelines for the treatment of depression (58) and the potential genetic vulnerability leading to comorbid depression and CVD (59), we may need to consider race or country (culture)-specific risk factors for CVD when aggregating measures of association across regions. Our findings of a lower risk of non-fatal CVD events with depression in studies including subjects with a prior CVD history compared J o u r n a l P r e -p r o o f with studies excluding those with prior CVD events at baseline indicate that the risk of primary and secondary CVD events among diabetic patients might differ (i.e. larger effects of depression on primary CVD events compared with secondary CVD events). However, we cannot rule out the possibility that the history of CVD events in patients with depression might be so disabling that they cannot be enrolled in studies (i.e. bias towards the null). Pharmacological management of depression specific to patients with a prior CVD (59) and careful follow-up of such patients might also contribute to the observed difference. Further investigations would be needed to validate these hypotheses.

Using bias analysis, we also demonstrated that uncontrolled confounding alone is unlikely to sufficiently explain our findings. Given that depression and CVD share environmental and lifestyle risk factors such as socioeconomic status, social adversity, smoking, and physical inactivity (6), uncontrolled confounding is one of the important issues in observational studies that prevents us from infering a causal relationship between depression and CVD events. In the present study, we focused on unemployment because none of the included studies controlled for this variable (except one study that included only employed individuals) despite prior findings that unemployment is one of the major risk factors of depression (13) and CVD (14) . Our bias analysis indicated that unemployment status among diabetic patients would have needed to have a very strong association with both depression and CVD. According to the previously reported association with an HR of 1.74 between unemployment and CVD events risk (14) , failing to control for unemployment may not fully explain the observed association between depression and CVD among patients with type 2 diabetes. Furthermore, given the current unemployment crisis due to the COVID-19 pandemic (60), the potential role of employment status and its J o u r n a l P r e -p r o o f sequela such as access to health insurance and health care in diabetes epidemiology would require more attention than ever. Thus, our bias analysis emphasizes the importance of this factor as a potential confounder in future diabetes-related research.

Our study has several limitations. First, a bias analysis for uncontrolled confounding does not remove the possibility that the selected cohort studies may have suffered from other sources of bias such as measurement error and selection bias. Most cohort studies included in this metaanalysis rely on self-reports of diabetes, which may lead to misclassification. The bias from such misclassifications is most likely non-differential with respect to CVD outcome events, and thus would bias the measure of association towards the null, if at all. Selection bias could also be induced by a differential loss to follow up in each study given that some studies identified CVD events by self-report (27, 32, 36, 41) . Second, manifestations of CVD events might be heterogeneous across the studies included in this meta-analysis. For example, the study by Scherrer et al (33) defined myocardial infarction incidence as their primary outcome, while the study by Wang et al (42) estimated the risk of heart failure incidence. Third, depression and type 2 diabetes have bidirectional associations, but most studies included in this meta-analysis do not specify which condition developed first. When diabetes is a confounder of the association between depression and CVD outcomes, the stratification by diabetes status (described as [Type Supplementary Figure 4) would remove the confounding bias due to diabetes. However, it is also possible that diabetes occurred after the development of depression. In this scenario, diabetes would be a mediator between depression and CVD outcomes, and conditioning on diabetes would not allow us to accurately estimate the total effects of depression on CVD outcomes. To overcome these limitations, further longitudinal studies with clear causal J o u r n a l P r e -p r o o f ordering and consistent definitions of depression, diabetes, and CVD will be necessary. Fourth, as type 1 diabetes has different biological and socio-behavioral mechanisms from type 2 diabetes, our result may not extend to patients with type 1 diabetes. Finally, this meta-analysis cannot conclude whether treating depressive symptoms in diabetic patients will be effective in reducing CVD risks, while reducing depressive symptoms will certainly improve health-related quality of life.

In conclusion, the present meta-analysis found that depression is associated with an increased risk of non-fatal and fatal CVD events. Our bias analysis showed that the observed association between depression and CVD events may not be entirely explained by confounding due to uncontrolled factors such as unemployment. J o u r n a l P r e -p r o o f 

Cardiovascular diseases (CVDs)

IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030

NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4. The Lancet

The link between depression and diabetes: the search for shared mechanisms

Type 2 diabetes mellitus and psychological stress -a modifiable risk factor

Depression and coronary heart disease

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

The prevalence of comorbid depression in adults with diabetes: a meta-analysis

Constructs of depression and distress in diabetes: time for an appraisal

Depression and risk of mortality in people with diabetes mellitus: a systematic review and meta-analysis

The Burden of Cardiovascular Diseases Among US States

Socioeconomic Status and Cardiovascular Outcomes: Challenges and Interventions

Unemployment and subsequent depression: A mediation analysis using the parametric G-formula

Unemployment is associated with high cardiovascular event rate and increased all-cause mortality in middle-aged socially privileged individuals

The contribution of diet and lifestyle to socioeconomic inequalities in cardiovascular morbidity and mortality

Bias Analysis for Uncontrolled Confounding in the Health Sciences

Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis

Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group

Interaction revisited: the difference between two estimates

Depression and risk of mortality in individuals with diabetes: a meta-analysis and systematic review

Operating characteristics of a rank correlation test for publication bias

Bias in meta-analysis detected by a simple, graphical test

Meta-analysis in clinical trials

Quantifying heterogeneity in a meta-analysis

Measuring inconsistency in meta-analyses

Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes

Depression and all-cause and coronary heart disease mortality among adults with and without diabetes

Depression and diabetes: a potentially lethal combination

Increased mortality risk in women with depression and diabetes mellitus

Increased risk of myocardial infarction in depressed patients with type 2 diabetes

Depression predicts all-cause mortality: epidemiological evaluation from the ACCORD HRQL substudy

Depression and death in diabetes; 10-year follow-up of all-cause and cause-specific mortality in a diabetic cohort

Consequences of Comorbidity of Elevated Stress and/or Depressive Symptoms and Incident Cardiovascular Outcomes in Diabetes: Results From the REasons for Geographic And Racial Differences in Stroke (REGARDS) Study

Increased Risk of Incident Chronic Kidney Disease, Cardiovascular Disease, and Mortality in Patients With Diabetes With Comorbid Depression

A prospective study of depression and mortality in patients with type 2 diabetes: the Fremantle Diabetes Study

Association of coexisting diabetes and depression with mortality after myocardial infarction

High risk for cardiovascular disease in Chinese type 2 diabetic patients with major depression--a 7-year prospective analysis of the Hong Kong Diabetes Registry

Comorbid Anxiety and Depression and Their Impact on Cardiovascular Disease in Type 2 Diabetes: The Fremantle Diabetes Study Phase II

Association of depression with evolution of heart failure in patients with type 2 diabetes mellitus

Depression, treatable cardiovascular risk factors and incident cardiac events in the Gazel cohort

Comorbid depression and risk of cardiac events and cardiac mortality in people with diabetes: A systematic review and meta-analysis

Longitudinal associations between depression and diabetes complications: a systematic review and meta-analysis

Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics

Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression

Arterial endothelial function is impaired in treated depression

Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials

Exaggerated serotonin-mediated platelet reactivity as a possible link in depression and acute coronary syndromes

The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes

Effect of smoking and sedentary behavior on the association between depressive symptoms and mortality from coronary heart disease

Exercise, depression, and mortality after myocardial infarction in the ENRICHD trial

Major depression and medication adherence in elderly patients with coronary artery disease

Comparison of guidelines for the treatment of unipolar depression: a focus on pharmacotherapy and neurostimulation

Author Contributions: All authors had full access to all of the data in the study and took J o u r n a l P r e -p r o o f